Functionally, the increased expression of CD25 and IL-2 responsiveness of transitional TH cells from patients with MS may provide the substrate for pathogenic CD4+ effector memory T cells in the inflamed CNS, as previously proposed11,46. This evidence concerns the gene CD4 and myeloid sarcoma.